GB9226860D0 - Novel treatment - Google Patents

Novel treatment

Info

Publication number
GB9226860D0
GB9226860D0 GB929226860A GB9226860A GB9226860D0 GB 9226860 D0 GB9226860 D0 GB 9226860D0 GB 929226860 A GB929226860 A GB 929226860A GB 9226860 A GB9226860 A GB 9226860A GB 9226860 D0 GB9226860 D0 GB 9226860D0
Authority
GB
United Kingdom
Prior art keywords
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929226860A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Priority to GB929226860A priority Critical patent/GB9226860D0/en
Publication of GB9226860D0 publication Critical patent/GB9226860D0/en
Priority to PCT/DK1993/000426 priority patent/WO1994014453A1/en
Priority to NZ259318A priority patent/NZ259318A/en
Priority to EP94903742A priority patent/EP0675722A1/en
Priority to AU58088/94A priority patent/AU678800B2/en
Priority to JP6514698A priority patent/JPH08504776A/en
Priority to CA002150827A priority patent/CA2150827A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
GB929226860A 1992-12-23 1992-12-23 Novel treatment Pending GB9226860D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB929226860A GB9226860D0 (en) 1992-12-23 1992-12-23 Novel treatment
PCT/DK1993/000426 WO1994014453A1 (en) 1992-12-23 1993-12-17 Hydroxy vitamin d3 compounds for treating skin atrophy
NZ259318A NZ259318A (en) 1992-12-23 1993-12-17 Use of vitamin d analogues in the treatment of steroid-induced skin atrophy
EP94903742A EP0675722A1 (en) 1992-12-23 1993-12-17 Hydroxy vitamin d3 compounds for treating skin atrophy
AU58088/94A AU678800B2 (en) 1992-12-23 1993-12-17 Hydroxy vitamin D3 compounds for treating skin atrophy
JP6514698A JPH08504776A (en) 1992-12-23 1993-12-17 Hydroxyvitamin D3 compounds for treating skin atrophy
CA002150827A CA2150827A1 (en) 1992-12-23 1993-12-17 Hydroxy vitamin d3 compounds for treating skin atrophy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226860A GB9226860D0 (en) 1992-12-23 1992-12-23 Novel treatment

Publications (1)

Publication Number Publication Date
GB9226860D0 true GB9226860D0 (en) 1993-02-17

Family

ID=10727144

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929226860A Pending GB9226860D0 (en) 1992-12-23 1992-12-23 Novel treatment

Country Status (7)

Country Link
EP (1) EP0675722A1 (en)
JP (1) JPH08504776A (en)
AU (1) AU678800B2 (en)
CA (1) CA2150827A1 (en)
GB (1) GB9226860D0 (en)
NZ (1) NZ259318A (en)
WO (1) WO1994014453A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ284261B6 (en) * 1993-09-01 1998-10-14 Teijin Limited COSMETIC AND PHARMACEUTICAL PREPARATION BASED ON 1ALPHA,24-(OH)i2-VITAMIN Di3 FOR SKIN CARE AND FOR TREATING SKIN DISEASES
EP0711558A1 (en) * 1994-10-21 1996-05-15 Unilever Plc Compositions for topical application to skin, hair and nails
DE19744127B4 (en) * 1997-10-01 2006-10-05 Schering Ag New vitamin D derivatives with side-chain cyclopropyl rings, processes and intermediates for their preparation and their use in the manufacture of medicaments
JP4511639B2 (en) * 1997-12-09 2010-07-28 中外製薬株式会社 Cream containing vitamin D3 derivative
NZ500769A (en) * 1998-03-04 2001-04-27 Teijin Ltd Activated dihydroxy- and hydroxyvitamin D3 emulsion-type lotions for treating psoriasis
MXPA01010676A (en) † 1999-04-23 2003-08-20 Leo Pharm Prod Ltd Pharmaceutical composition.
JP3668225B2 (en) * 2000-08-30 2005-07-06 中外製薬株式会社 OCT formulation
DK1331927T3 (en) 2000-10-27 2008-05-05 Leo Pharma As Topical composition containing at least one vitamin D or vitamin D analogue and at least one dietary chosteroid
ATE341539T1 (en) 2001-01-26 2006-10-15 Chugai Pharmaceutical Co Ltd MALONYL COA-DECARBOXYLASE INHIBITORS AS METABOLISM MODULATORS
WO2002058690A2 (en) 2001-01-26 2002-08-01 Chugai Seiyaku Kabushiki Kaisha Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
ATE509014T1 (en) 2001-01-26 2011-05-15 Chugai Pharmaceutical Co Ltd MALONYL COA-DECARBOXYLASE INHIBITORS AS METABOLISM MODULATORS
US7709510B2 (en) 2001-02-20 2010-05-04 Chugai Seiyaku Kabushiki Kaisha Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
EP1379243B1 (en) 2001-02-20 2009-09-09 Chugai Seiyaku Kabushiki Kaisha Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors
CA2533881C (en) 2003-08-01 2012-07-10 Chugai Seiyaku Kabushiki Kaisha Cyanoguanidine-based azole compounds useful as malonyl-coa decarboxylase inhibitors
ES2295930T3 (en) 2003-08-01 2008-04-16 Chugai Seiyaku Kabushiki Kaisha CIANOAMIDE COMPOUNDS USED AS MALONIL-COA DESCARBOXYLASE INHIBITORS.
EP1653944B1 (en) 2003-08-01 2010-11-10 Chugai Seiyaku Kabushiki Kaisha Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
US7449482B2 (en) 2003-08-01 2008-11-11 Chugai Seiyaku Kabushiki Kaisha Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors
GB0513984D0 (en) * 2005-07-07 2005-08-17 Teva Pharma Dosage form
KR20110113664A (en) * 2006-08-29 2011-10-17 테바 파마슈티컬 인더스트리즈 리미티드 Pharmaceutical compositions including vitamin d and corticosteroid
US8377913B2 (en) * 2007-11-20 2013-02-19 Abbvie Inc. Vitamin D receptor activators and methods of making
KR101641372B1 (en) * 2015-05-08 2016-07-20 (주)동구바이오제약 A pharmaceutical formulation which shows enhanced stability and skin permeability

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9015774D0 (en) * 1990-07-18 1990-09-05 Leo Pharm Prod Ltd Novel treatment
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
GB9214202D0 (en) * 1992-07-03 1992-08-12 Leo Pharm Prod Ltd Chemical compounds

Also Published As

Publication number Publication date
EP0675722A1 (en) 1995-10-11
AU678800B2 (en) 1997-06-12
AU5808894A (en) 1994-07-19
WO1994014453A1 (en) 1994-07-07
CA2150827A1 (en) 1994-07-07
JPH08504776A (en) 1996-05-21
NZ259318A (en) 1997-08-22

Similar Documents

Publication Publication Date Title
GB9215633D0 (en) Novel treatment
GB9208339D0 (en) Treatment composition
GB9127150D0 (en) Novel treatment
GB9226860D0 (en) Novel treatment
GB9211148D0 (en) Novel treatment
GB9203039D0 (en) Treatment
GB9225860D0 (en) Novel treatment
GB9226957D0 (en) Novel treatment
GB9226958D0 (en) Produktionsaktieselskab) novel treatment
GB9308802D0 (en) Treatment
ZA933376B (en) Novel treatment
GB9203637D0 (en) Novel treatment
GB9225859D0 (en) Novel treatment
GB9225857D0 (en) Novel treatment
GB9225861D0 (en) Novel treatment
GB9225964D0 (en) Novel treatment
GB9225963D0 (en) Novel treatment
GB9225961D0 (en) Novel treatment
GB9225959D0 (en) Novel treatment
GB9225957D0 (en) Novel treatment
GB9225956D0 (en) Novel treatment
GB9225862D0 (en) Novel treatment
AP9200456A0 (en) Novel treatment
GB9214209D0 (en) Novel treatment
GB9207219D0 (en) Novel treatment